The term 'macroglobulinaemia' was first introduced by Waldenstrom (1944) to describe a syndrome characterized by the presence of large quantities of circulating globulins of high molecular weight. Small amounts of macroglobulin may be found in normal plasma, but for diagnosis of the pathological state, macroglobulins, with a sedimentation value of S20 w16 or more, should constitute at least 10% of the total plasma proteins (Martin, 1960) . Macroglobulins may sometimes occur as an associated feature of diseases such as chronic lymphatic leukaemia and lymphosarcoma. But in some patients no such disease can be found, and these constitute primary or essential macroglobulinaemia of Waldenstrom. Irrespective of its exact aetiological basis, the well-defined abnormality of the serum proteins and the generally recognizable clinical picture make it useful to accept macroglobulinaemia as a disease entity; for many of the clinical features, as for example, the abnormal bleeding tendency, the development of retinopathy, heart failure, and the neurological manifestations, would appear to be the consequence of the high concentration of circulating globulins (Kappeler, Krebs, and Riva, 1958; MacKay 1959; Ritzmann, Thurm, Truax, and Levin, 1960b) .
Response to treatment of Waldenstrom's macroglobulinaemia is often disappointing. Steroids and A.C.T.H. produce transient benefit (Glenchur, Zinneman, and Briggs, 1958; MacKay, 1959; Ritzmann et al., 1960b) . Whereas experience with cytotoxic agents has been conflicting, early reports suggested that alkylating agents had little effect (Glenchur et al., 1958; Kappeler et al., 1958; Wintrobe, 1961) , although recently, a response to chlorambucil has been recorded (Bayrd, 1961; Clatanoff and Meyer, 1963) . This paper describes a Received for publication 14 July 1965. further case of Waldenstrom's macroglobulinaemia successfully treated with long-term cytotoxic therapy.
CLINICAL DETAILS
A 50-year-old married woman was admitted to hospital complaining of weakness, lassitude, and swollen glands. During the preceding six months she had noticed swelling of the glands in her neck and had become progressively more weak and tired. In the last three months she had noticed increasing shortness of breath and palpitations on exertion. Her appetite had become impaired and she had lost one stone in weight. In addition, she bruised more easily and had had four small haemoptyses in the last year.
On examination, she was anaemic and there were scattered bruises on the arms and legs. The cervical and supraclavicular lymph glands were slightly enlarged, but there was no lymphadenopathy elsewhere. The liver was palpable 2 cm. below the costal margin but the spleen could not be felt. The ocular fundi showed distension and tortuosity of the retinal veins, but no haemorrhages could be seen. Examination was otherwise normal.
INVESTIGATION The haemoglobin concentration was 50% (7 4 g./100 ml.), the red cells numbered 3 0 millions/ c.mm. and the indices were normal, but marked rouleaux formation was present. The white cell count was 3,700/ c.mm. (polymorphonuclear leucocytes 36 %, lymphocytes 56 %, and monocytes 7 %); no immature cells were present. The platelet count was 200,000/c.mm. The erythrocyte sedimentation rate was 160 mm. in the first hour (Westergren). The direct antiglobulin (Coombs) test was negative, the prothrombin time was 50% of normal (15 sec.), and the bleeding and clotting times were within normal limits. The plasma protein concentration was 7-5 g./100 ml., albumin 3-1 and globulin 4-4 g./100 ml. Paper electrophoresis showed an intense, well-defined band in the gamma globulin region. Quantitation of this component showed it to comprise 30% of the total plasma protein and to amount to a concentration of 55 R. M. Buckle, G. C. Jenkins, and G. L. Mills (Fig. I a) .
TREATMENT AND PROGRESS The patient was transfused with 8 pints of blood. Treatment was started with penicillamine (3/-dimethyl cysteine) 0 9 g. increasing to 1-8 g./day (as four divided doses) for three weeks. This had no effect on the clinical state. There was no appreciable change in the serum proteins (Fig. 2) (S20 199) to have fallen to 022 g./l00 ml.
( Fig. Ib) . Subsequently, a fall in the peripheral white cell count necessitated reduction in the dosage of cyclophosphamide to 100 mg./day. No change occurred in the total concentration of serum globulin, but ultracentrifugation showed a rise in the concentration of macroglobulin to 0 82 g./100 ml., a value which comprised 11.9% of the total serum protein (Fig. ic) .
After six months' treatment, the patient noticed that her hair was beginning to fall out; cyclophosphamide was therefore stopped and chlorambucil substituted, in a dosage of 6 to 10 mg./day, later being reduced to a maintenance level of 2 to 4 mg./day. During the last 14 months' of treatment with chlorambucil the serum globulin has remained between 2-2 and 1 5 g./100 ml. (Fig. 2) . The Sia test has remained negative, and ultracentrifugation shows the concentration of circulating macroglobulin of S20 17-2 to be reduced to a value of 039 g./100 ml. (6-2% of the total serum protein), an amount equal to one-sixth of the initial value (Fig. Id) . The patient's initial clinical improvement has been maintained; the fundi have remained normal, there has been no recurrence of lymphadenopathy and no abnormal bleeding. The haemoglobin has remained above 60 % and no further transfusions have been required. During the whole course of treatment the patient's general health has been satisfactory and there has been complete relief of symptoms. In addition to performing her normal household duties, she has continued to go out to work.
DISCUSSION
The high concentration of circulating macroglobulin is thought to be responsible for some of the clinical manifestations of the syndrome (MacKay, Eriksen, Motulsky, and Volwiler, 1956; Kappeler et al., 1958; MacKay, 1959) , for the disturbance of blood clotting and interference with normal capillary and platelet function may predispose to bleeding, whilst the increased viscosity of the plasma may contribute to the development of heart failure and be responsible for the occurrence of retinal changes (Spalter, 1959) . Cellular infiltration and deposition of abnormal protein in the perivascular spaces may account for the neurological disturbances that occur (Logothetis, Silverstein, and Coe, 1960) . Treatment should therefore aim at reducing the concentration of circulating macroglobulins. Removal of the abnormal proteins by plasmapheresis or exchange transfusion may be a useful emergency procedure (Schwab and Fahey, 1960;  Conway and Walker, 1962) . But the practical value of such treatment is limited, for the improvement is only temporary and the concentration of circulating macroglobulins returns to its former level within two to three weeks (Skoog, Adams, and Coburn, 1962) .
Depolymerization of the macroglobulins with a consequent reduction in the viscosity of the plasma can be achieved in vitro by the addition of thiols of low molecular weight such as mercaptoethanol or fl-dimethyl cysteine (Deutsch and Morton, 1958; Glenchur et al., 1958) , whilst on occasion, reduction of circulating macroglobulin has also been achieved in patients given penicillamine (fl-dimethyl cysteine) by mouth (Bloch, Prasad, Ananstasi, and Briggs, 1960; Ritzmann, Coleman, and Levin, 1960a) . However, Conway and Walker (1962) (Glenchur et al., 1958; MacKay, 1959; Ritzmann et al., 1960b; Kok, Whitmore, and Ainsworth, 1963) , although a more prolonged improvement has been recorded (Pitney, O'Sullivan, and Owen, 1958; Fairley, 1963) . Likewise, x-irradiation and P32 therapy are of limited value (MacKay et al., 1956) . The results of treatment with cytotoxic agents have been conflicting. Early studies suggested that alkylating agents had little effect (Kappeler et al., 1958; Glenchur et al., 1958; Ritzmann, et al. 1960b; Wintrobe, 1961) , but a reduction of macroglobulin following prolonged treatment with chlorambucil has been reported by Bayrd (1961) and more recently by Clatanoff and Meyer (1963) Clatanoff and Meyer (1963) .
Evidence suggests that macroglobulins arise from the abnormal synthetic activity of lymphocytoid cells (Zucker-Franklin, Franklin, and Cooper, 1962) , and it is probable that macroglobulinaemia should be regarded as a syndrome rather than as a distinct disease entity (Martin, 1960) . Macroglobulinaemia may occur as an incidental feature in established cases of chronic lymphatic leukaemia, lymphosarcoma, or Hodgkin's disease, and treatment of the primary disorder with alkylating agents may cause the concentration of macroglobulins to fall (MacKay et al. 1956; Fairley, 1963) . On the other hand, in primary macroglobulinaemia of Waldenstrom the accumulation of macroglobulins in the blood is the dominant feature of the disease, although reticulo-endothelial tissue may show a characteristic proliferation of lymphocytoid and plasma-like cells (Zollinger, 1958; Kok et al., 1963 ). Waldenstrom's macroglobulinaemia may therefore be classified amongst the lymphoproliferative states (Hayhoe, 1960; Wintrobe, 1961) , and like them, long-term treatment with alkylating agents, such as cyclophosphamide and chlorambucil, may result in a satisfactory remission of the disease.
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